Buy Stocks Easy | About Us
April 17, 2021
Buy Stocks Easy | Online Stocks

DNLI


Buy Denali Therapeutics Inc. Stock (symbol: DNLI) Easy Online

Company Name: Denali Therapeutics Inc.

Symbol: DNLI

Sector: Health Care

Industry: Biotechnology: Biological Products (No Diagnostic Substances)

IPO: 2018

DNLI Current Share Price

Today's DNLI ( Denali Therapeutics Inc. ) opening price: $

Yesterday's DNLI ( Denali Therapeutics Inc. ) closing price: $

Denali Therapeutics Inc. Stock ( symbol: DNLI ) Price Chart since IPO (2018):

12 Months Denali Therapeutics Inc. Stock ( symbol: DNLI ) Price Chart

Popular Questions about Denali Therapeutics Inc. Public Stock ( DNLI )

A: Denali Therapeutics Inc. stock symbol (also called stock or share ticker) is DNLI

A: Denali Therapeutics Inc. IPO (Initial Public Offering) took place on 2018

A: Denali Therapeutics Inc.'s stock (DNLI symbol) price at ther IPO (initial Public Offering) was $

Q: Is DNLI stock worth buying at the moment?

A: If you were looking for a long-term investment portfolio and had bought the 'Denali Therapeutics Inc. stock (symbol: DNLI) at the beginning of 2019, at the opening share price of $19.0600, with a minimum of $200, by now your shares would be worth $2298 and your profit would be $2098 - SHOW ONLY IF PROFIT.

Buy Denali Therapeutics Inc. Stock Easy Online

Denali Therapeutics Inc. Stock Ticker Price Chart since IPO:





Denali Therapeutics Inc. Stock Price Yesterday



 


Denali Therapeutics Inc. Stock Price – Last Week




 


Denali Therapeutics Inc. Stock Price – Last Month




 


Denali Therapeutics Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.zacks.com/stock/news/652400/options-traders-expect-huge-moves-in-denali-dnli-stock
                            

                                
Options Traders Expect Huge Moves in Denali (DNLI) Stock

                                
                                
Investors need to pay close attention to Denali (DNLI) stock based ...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2019/11/09/2-biotech-stocks-fighting-alzheimers-disease-to-ow.aspx
                            

                                
2 Biotech Stocks Fighting Alzheimer’s Disease to Own Now

                                
                                
No new drugs have been approved for Alzheimer’s disease since 2003....


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/607265/denali-therapeutics-inc-dnli-reports-q3-loss-tops-revenue-estimates
                            

                                
Denali Therapeutics Inc. (DNLI) Reports Q3 Loss, Tops Revenue Estimates

                                
                                
Denali Therapeutics Inc. (DNLI) delivered earnings and revenue surp...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/04/1910858/0/en/Denali-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1b-Study-of-DNL151-for-Parkinson-s-Disease-and-Launch-of-Its-Engage-Parkinson-s-Website.html
                            

                                
Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL151 for Parkinson’s Disease and Launch of Its Engage Parkinson’s Website

                                
                                
SOUTH SAN FRANCISCO, Calif., Sept.  04, 2019  (GLOBE NEWSWIRE) -- D...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/460214/denali-therapeutics-inc-dnli-reports-q2-loss-lags-revenue-estimates
                            

                                
Denali Therapeutics Inc. (DNLI) Reports Q2 Loss, Lags Revenue Estimates

                                
                                
Denali Therapeutics Inc. (DNLI) delivered earnings and revenue surp...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4269876-denali-therapeutics-key-catalysts-coming-neurodegenerative-disease-pioneer?source=feed_tag_long_ideas
                            

                                
Denali Therapeutics: Key Catalysts Coming Up For This Neurodegenerative Disease Pioneer

                                
                                
Shares have risen by just 5% since December 2017 IPO.


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/652400/options-traders-expect-huge-moves-in-denali-dnli-stock
                            

                                
Options Traders Expect Huge Moves in Denali (DNLI) Stock

                                
                                
Investors need to pay close attention to Denali (DNLI) stock based ...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2019/11/09/2-biotech-stocks-fighting-alzheimers-disease-to-ow.aspx
                            

                                
2 Biotech Stocks Fighting Alzheimer’s Disease to Own Now

                                
                                
No new drugs have been approved for Alzheimer’s disease since 2003....


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/607265/denali-therapeutics-inc-dnli-reports-q3-loss-tops-revenue-estimates
                            

                                
Denali Therapeutics Inc. (DNLI) Reports Q3 Loss, Tops Revenue Estimates

                                
                                
Denali Therapeutics Inc. (DNLI) delivered earnings and revenue surp...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/04/1910858/0/en/Denali-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1b-Study-of-DNL151-for-Parkinson-s-Disease-and-Launch-of-Its-Engage-Parkinson-s-Website.html
                            

                                
Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL151 for Parkinson’s Disease and Launch of Its Engage Parkinson’s Website

                                
                                
SOUTH SAN FRANCISCO, Calif., Sept.  04, 2019  (GLOBE NEWSWIRE) -- D...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/460214/denali-therapeutics-inc-dnli-reports-q2-loss-lags-revenue-estimates
                            

                                
Denali Therapeutics Inc. (DNLI) Reports Q2 Loss, Lags Revenue Estimates

                                
                                
Denali Therapeutics Inc. (DNLI) delivered earnings and revenue surp...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4269876-denali-therapeutics-key-catalysts-coming-neurodegenerative-disease-pioneer?source=feed_tag_long_ideas
                            

                                
Denali Therapeutics: Key Catalysts Coming Up For This Neurodegenerative Disease Pioneer

                                
                                
Shares have risen by just 5% since December 2017 IPO.


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.